Haploidentical hematopoietic stem cell transplantation in children with high-risk hematologic malignancies: outcomes with two different strategies for GvHD prevention. Ex vivo T-cell depletion and post-transplant cyclophosphamide: 10 years of experience at a single center-Reference-Cited by-同舟云学术

Haploidentical hematopoietic stem cell transplantation in children with high-risk hematologic malignancies: outcomes with two different strategies for GvHD prevention. Ex vivo T-cell depletion and post-transplant cyclophosphamide: 10 years of experience at a single center

Published:2016-06-06 Issue:10 Volume:51 Page:1354-1360
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Dufort G,Castillo L,Pisano S,Castiglioni M,Carolina P,Andrea I,Simon E,Zuccolo S,Schelotto M,Morosini F,Pereira I,Amarillo P,Silveira A,Guerrero L,Ferreira V,Tiscornia A,Mezzano R,Lemos F,Boggia B,Quarnetti A,Decaro J,Dabezies A

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/bmt2016161.pdf

Reference27 articles.

1. Schumm M, Lang P, Taylor G, Kuçi S, Klingebiel T, Bühring HJ et al. Isolation of highly purified autologous and allogeneic peripheral CD34+ cells using the CliniMACS device. J Hematother 1999; 8: 209–218.

2. Handgretinger R, Klingebiel T, Lang P, Schumm M, Neu S, Geiselhart A et al. Megadose transplantation of purified peripheral blood CD34+ progenitor cells from HLA-mismatched parental donors in children. Bone Marrow Transplant 2001; 27: 777–783.

3. Aversa F, Terenzi A, Tabilio A, Falzetti F, Carotti A, Ballanti S et al. Full haplotype-mismatched hematopoietic stem-cell transplantation: a phase II study in patients with acute leukemia at high risk of relapse. J Clin Oncol 2005; 23: 3447–3454.

4. Dufort G, Pisano S, Incoronato A, Castiglioni M, Carracedo M, Pages C et al. Feasibility and outcome of haploidentical SCT in pediatric high-risk hematologic malignancies and Fanconi anemia in Uruguay. Bone Marrow Transplant 2012; 47: 663–668.

5. Handgretinger R, Chen X, Pfeiffer M, Mueller I, Feuchtinger T, Hale GA et al. Feasibility and outcome of reduced-intensity conditioning in haploidentical transplantation. Ann NY Acad Sci 2007; 1106: 279–289.

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Haploidentical hematopoietic cell transplantation with or without an unrelated cord blood unit for adult acute myeloid leukemia: a multicenter, randomized, open-label, phase 3 trial;Signal Transduction and Targeted Therapy;2024-05-06

2. Post-transplant cyclophosphamide or cell selection in haploidentical allogeneic hematopoietic cell transplantation?;Hematology;2024-04-10

3. A comparison of <i>ex vivo</i> and <i>in vivo</i> T-cell depletion for hematopoietic stem cell transplantation in children with malignant blood disorders;Pediatric Hematology/Oncology and Immunopathology;2024-04-08

4. Human Leukocyte Antigen–Haploidentical Haematopoietic Stem Cell Transplantation Using Post-Transplant Cyclophosphamide for Paediatric Haematological Malignancies;Cancers;2024-01-31

5. Efficacy and safety of letermovir prophylaxis for cytomegalovirus infection after hematopoietic stem cell transplantation;Blood Science;2024-01